Researcher Publication Search

Name: Catherine Roe
Year: 2016

Reference:

Roe CM, Babulal GM, Head DM, Stout SH, Vernon EK, Ghoshal N, Garland B, Barco PP, Williams MM, Johnson A, Fierberg R, Fague MS, Xiong C, Mormino E, Grant EA, Holtzman DM, Benzinger TLS, Fagan AM, Ott BR, Carr DB, Morris JC. Preclinical Alzheimer disease and longitudinal driving decline. Alzheimer’s & Dementia: Translational Research & Clinical Interventions. 2016. doi: 10.1016/j.trci.2016.11.006. (in press)

Name: Anne Fagan
Year: 2016

Reference:

Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague S, Xiong C, Grant EA, Campbell A, Ott BR, Holtzman DM, Benzinger TL, Fagan AM, Carr DB, Morris JC. Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals. Alzheimer Dis Assoc Disord. 2016 Apr 28. PMID: 27128959

Name: Catherine Roe
Year: 2016

Reference:

Roe CM, Barco PP, Head DM, Ghoshal N, Selsor N, Babulal GM, Fierberg R, Vernon EK, Shulman N, Johnson A, Fague S, Xiong C, Grant EA, Campbell A, Ott BR, Holtzman DM, Benzinger TLS, Fagan AM, Carr DB, Morris JC. Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals. Alzheimer Disease and Associated Disorders. 2016. doi: 10.1097/WAD.0000000000000154. PMID: 27128959. PMCID: PMC5085874

Name: Suzanne Schindler
Year: 2016

Reference:

Schindler SE, Holtzman DM. CSF sTREM2: marking the tipping point between preclinical AD and dementia? 2016 May 2;8(5)437-8. PMID: 26976613

Name: Kevin Black
Year: 2016

Reference:

Siddiqi SH, Abraham NK, Geiger CL, Karimi M, Perlmutter JS, Black KJ. The Human Experience with Intravenous Levodopa. Frontiers in Pharmacology 2016 Jan 6;6:307. doi: 10.3389/fphar.2015.00307. PubMed PMID: 26779024; PubMed Central PMCID: PMC4701937.

Name: Anne Fagan
Year: 2016

Reference:

Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, Ghetti B, Graff-Radford NR, Laske C, Martins RN, Masters CL, Mayeux RP, Ringman JM, Rossor MN, Salloway SP, Schofield PR, Morris JC, Bateman RJ; Dominantly Inherited Alzheimer Network (DIAN)
Neurological manifestations of autosomal dominant familial Alzheimer’s disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol. 2016 Oct 21. (16)30229-0. PMCID: PMC5116769

Name: Anne Fagan
Year: 2016

Reference:

Tang M, Ryman DC, McDade E, Jasielec MS, Buckles VD, Cairns NJ, Fagan AM, Goate A, Marcus DS, Xiong C, Allegri RF, Chhatwal JP, Danek A, Farlow MR, Fox NC, Ghetti B, Graff-Radford NR, Laske C, Martins RN, Masters CL, Mayeux RP, Ringman JM, Rossor MN, Salloway SP, Schofield PR, Morris JC, Bateman RJ; Dominantly Inherited Alzheimer Network (DIAN)
Neurological manifestations of autosomal dominant familial Alzheimer’s disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol. 2016 Oct 21. (16)30229-0. PMCID: PMC5116769

Name: Anne Fagan
Year: 2016

Reference:

Tarawneh R, D’Angelo G, Crimmins D, Herries E, Griest T, Fagan AM, Zipfel GJ, Ladenson JH, Morris JC, Holtzman DM. Diagnostic And Prognostic Utility of The Synaptic Marker Neurogranin In Alzheimer Disease. JAMA Neurol. 2016 Mar 28. doi: 10.1001/jamaneurol.2016.0086. NIHMS774455

Name: Nigel Cairns
Year: 2016

Reference:

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease.
Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TL, Ances BM.
Sci Transl Med. 2016 May 11;8(338):338ra66. doi: 10.1126/scitranslmed.aaf2362.
PMID:27169802 PMC in progress

Name: Tammie Benzinger
Year: 2016

Reference:

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease.
Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TL, Ances BM.
Science translational medicine. 2016; 8(338):338ra66.
PubMed [journal]PMID: 27169802

Name: Tammie Benzinger
Year: 2016

Reference:

The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging.
Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, Aldea P, McConathy J, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances BM, Benzinger TL.
Brain : a journal of neurology. 2016; 139(Pt 8):2249-60.
PubMed [journal]PMID: 27286736 PMCID: PMC4958902

Name: Anne Fagan
Year: 2016

Reference:

Vlassenko AG, McCue L, Jasielec MS, Su Y, Gordon BA, Xiong C, Holtzman DM, Benzinger TL, Morris JC, Fagan AM. Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease. Ann Neurol. 2016 Jul 11. PMID: 27398953

Name: Anne Fagan
Year: 2016

Reference:

Vos SJ, Gordon BA, Su Y, Visser PJ, Holtzman DM, Morris JC, Fagan AM, Benzinger TL. NIA- AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers. Neurobiol Aging. 2016 Aug;44:1-8. PMCID: PMC4913039

Name: Brian Gordon
Year: 2016

Reference:

Vos, SJB, Gordon, BA, Su, Yi, Visser PJ, Cairns NJ, Holtzman, DH, Morris, JC, Fagan AM, Benzinger, TLS (in press). Preclinical Alzheimer disease stating: comparisons of CSF and imaging biomarkers. Neurobiology of Aging

Name: Anne Fagan
Year: 2016

Reference:

Wang L, Benzinger TL, Su Y, Christensen J, Friedrichsen K, Aldea P, McConathy J, Cairns NJ, Fagan AM, Morris JC, Ances BM. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy. JAMA Neurol. 2016 Jul 25. PMID: 27454922

Name: Nigel Cairns
Year: 2016

Reference:

White matter hyperintensities are a core feature of Alzheimer’s disease: Evidence from the dominantly inherited Alzheimer network.
Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, Marcus DS, Fagan AM, Goate A, Fox NC, Cairns NJ, Holtzman DM, Buckles V, Ghetti B, McDade E, Martins RN, Saykin AJ, Masters CL, Ringman JM, Ryan NS, Förster S, Laske C, Schofield PR, Sperling RA, Salloway S, Correia S, Jack C Jr, Weiner M, Bateman RJ, Morris JC, Mayeux R, Brickman AM; Dominantly Inherited Alzheimer Network.
Ann Neurol. 2016 Jun;79(6):929-39. doi: 10.1002/ana.24647. Epub 2016 Apr 27.
NIHMS772945

Name: Anne Fagan
Year: 2016

Reference:

Xiong C, Jasielec MS, Weng H, Fagan AM, Benzinger TL, Head D, Hassenstab J, Grant E, Sutphen CL, Buckles V, Moulder KL, Morris JC. Longitudinal relationships among biomarkers for Alzheimer disease in the Adult Children Study.Neurology. 2016 Mar 23 [Epub ahead of print]

Name: Anne Fagan
Year: 2016

Reference:

Zhao Y, Raichle ME, Wen J, Benzinger TL, Fagan AM, Hassenstab J, Vlassenko AG, Luo J, Cairns NJ, Christensen JJ, Morris JC, Yablonskiy DA. In vivo Detection of Microstructural Correlates of Brain Pathology in Preclinical and Early Alzheimer Disease with Magnetic Resonance Imaging. Neuroimage. 2016 Dec 15. PMID: 27989773

Name: Nigel Cairns
Year: 2015

Reference:

2. Guerreiro R, Escott-Price V, Darwent L, Parkkinen L, Ansorge O, Hernandez DG, Nalls MA, Clark L, Honig L, Marder K, van der Flier W, Holstege H, Louwersheimer E, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns NJ, Halliday GM, Mann D, Pickering-Brown S, Powell J, Lunnon K, Lupton MK; International Parkinson’s Disease Genomics Consortium (IPDGC), Dickson D, Hardy J, Singleton A, Bras J. 1. Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson’s and Alzheimer’s diseases. Neurobiol Aging. 2015 Nov 2. PMID: 26643944. PMC IN PROCESS

Name: Anne Fagan
Year: 2015

Reference:

Aschenbrenner AJ, Balota DA, Fagan AM, Duchek JM, Benzinger TL, Morris JC. Alzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study. J Int Neuropsychol Soc. 2015 Sep;21(8):573-83. PMCID: PMC4610253

Name: david balota
Year: 2015

Reference:

Aschenbrenner AJ, Balota DA, Fagan AM, Duchek JM, Benzinger TLS, Morris JC. Alzheimer disease cerebrospinal fluid biomarkers moderate baseline differences and predict longitudinal change in attentional control and episodic memory composites in the Adult Children Study. Journal of the International Neuropsychological Society 2015; 21: 573-583. PMCID: PMC4610253.

Name: Brian Gordon
Year: 2015

Reference:

Aschenbrenner AJ, Balota DA, Gordon BA, Ratcliff R, Morris JC. (in press). A diffusion model analysis of speeded episodic recognition in individuals with a family history of Alzheimer disease: The Adult Child Study. Neuropsychology.

Name: david balota
Year: 2015

Reference:

Aschenbrenner AJ, Balota DA, Tse CS, Fagan AM, Holtzman DM, Benzinger TLS, Morris JC. Alzheimer disease biomarkers, attentional control and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults. Neuropsychology 2015; 29: 368-381. PMCID: PMC4362851.

Name: david balota
Year: 2015

Reference:

Aschenbrenner AJ, Balota DA. Interactive effects of working memory and trial history on Stroop interference in cognitively healthy aging. Psychology and Aging 2015; 30: 1-8. PMCID: PMC4361384.

Name: Andrew Aschenbrenner
Year: 2015

Reference:

Aschenbrenner, A. J., Balota, D. A., Fagan, A. M., Duchek, J. M., Benzinger, T. L. S. & Morris, J. C. (2015). Alzheimer disease cerebrospinal fluid biomarkers moderate baseline differences and predict longitudinal change in attentional control and episodic memory composites in the Adult Children Study. Journal of the International Neuropsychological Society, 21, 573-583. doi:10.1017/S1355617715000776. PMID: PMC4610253